Last updated: 2026-09-06 20:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Alphatec Holdings, Inc. (ATEC) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.45, with a market capitalization of $1.42B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.82 to $23.29. This page covers its latest market performance, valuation, price trends and company information.
$1.42B | |
$9.22 | |
$108.00 | |
$1.18 | |
$9.33 | |
1.27M | |
-- | |
-- | |
$23.29 | |
$6.82 | |
-- | |
-- |
Alphatec Holdings, Inc. (ATEC) last closed at $9.33 as of 2026-09-04 23:33:00, unchanged from the previous close of $9.33.
During the latest regular trading session, ATEC traded between $1.18 and $108.00, with a volume of 1.27M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Alphatec Holdings, Inc. (ATEC) moved from $9.32 to $9.45, representing a gain of 1.35% ($0.13).
The stock traded between $9.10 and $9.51 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.44 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.9%
ATEC is currently trading at $9.45, placing it 15.9% of the way from its 52-week low of $6.82 to its 52-week high of $23.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 913 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alphatec Holdings, Inc. (ATEC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.